Acorda Therapeutics (ACOR)

Add to Watchlists
Create an Alert
34.97 -0.28  -0.79% NASDAQ Apr 24, 5:00PM BATS Real time Currency in USD
View Full Chart
ACOR Price Chart
View All Events

ACOR Events

Date Type Description
Feb 13 Misc Acorda Therapeutics, Inc. Q4 2013 Earnings Conference Call
Feb 13 Earnings Acorda Therapeutics, Inc. Q4 2013 Earnings Results. Estimate: 0.18.
Oct 31 Misc Acorda Therapeutics, Inc. Q3 2013 Earnings Conference Call
Oct 31 Earnings Acorda Therapeutics, Inc. Q3 2013 Earnings Release. Estimate: 0.10.
Aug 01 Misc Acorda Therapeutics to Host Conference Call to Discuss Second Quarter 2013 Financial Results on August 1, 2013
Aug 01 Earnings Second Quarter 2013 Financial Results. Estimate: 0.10.
Jul 09 Misc Acorda Therapeutics Announces Acquisition of Two Neuropathic Pain Assets
May 30 Misc AGM Event for Acorda Therapeutics Inc
May 02 Misc Q1 2013 Acorda Therapeutics, Inc. Earnings Conference Call
May 02 Earnings Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2013 Financial Results on May 2, 2013. Estimate: 0.15.
View All Performance Charts

ACOR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Acorda Therapeutics is down 10.84% over the last year vs S&P 500 Total Return up 21.54%, Actelion up 67.22%, and Vanda Pharmaceuticals up 191.2%.

Get Quote for

PDF Report for ACOR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ACOR Pro Report PDF

Portfolio Strategies Featuring ACOR

Did Acorda Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ACOR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Acorda Therapeutics is a biotechnology company based in Hawthorne, New York. Acorda Therapeutics develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda manufactures and markets the drugs Zanaflex and Ampyra in the United States. It also offers products for treatment, regeneration and repair of the brain. The company was founded by Ronald Cohen in 1995.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ACOR 34.97 -0.28 -0.79% 1.445B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.